Prognostic value of end-of-induction PET response after ...EM consulte
www.em-consulte.com
... Yuan Kai Shi, Gang Wu, Xiaonan Hong, Qingyuan Zhang, Jifeng Feng, Rong Zhan, Tongyu Lin, Sirpa Leppa, Regis Costello, Adrian Tempescul, Laurence Sanhes, ...
Radiotherapy followed by DICEP regimen in treatment of ...Directory of Open Access Journals
doaj.org
... Kai Xue,; Zuguang Xia,; Jia Jin,; Jiachen Wang,; Hui Sun,; Fangfang Lv,; Xiaojian Liu,; Junning Cao,; Xiaonan Hong,; Ye Guo,; Xuejun Ma,; Qunling Zhang.
a phase III study of lenalidomide plus rituximab UGent Bibliougent.be
biblio.ugent.be
von JP Leonard · · Zitiert von: 292 — Leonard, John P, Marek Trneny, Koji Izutsu, Nathan H Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S ...
Internet connection lostThe European Hematology Association
library.ehaweb.org
— Xiaonan Hong,. Xiaonan Hong. Affiliations: Fudan University Shanghai Cancer Center,Shanghai,China. Huilai Zhang,. Huilai Zhang.
Efficacy and time to next treatment following UGent Bibliobiblio.ugent.be › publication
biblio.ugent.be
Gribben, John G., Koji Izutsu, Nathan Hale Fowler, Xiaonan Hong, Huilai Zhang, Fritz Offner, Adriana A. S. Scheliga, et al “Efficacy and ...
NovartisAmerican Society of Clinical Oncology
coi.asco.org
Xiaonan Hong. No Relationships to Disclose. Huilai Zhang. No Relationships to Disclose. Fritz Offner. No Relationships to Disclose. Adriana A. S. Scheliga.
Program Guide – ASCO Meeting Program Guide
meetings.asco.org
John G. Gribben, Koji Izutsu, Nathan Hale Fowler, Xiaonan Hong, Huilai Zhang, Fritz Offner, Adriana A. S. Scheliga, Grzegorz S. Nowakowski, Antonio Pinto, ...
Phase I dose-escalating study of 24-h continuous infusion of...
www.proquest.com
Biyun Wang · Wen Zhang · Xiaonan Hong ·. Ye Guo · Jin Li. Received: 24 December Accepted: 2 March Published online:
Phase I dose-escalating study of 24-h continuous infusion ...CORE
core.ac.uk
von B Wang · · Zitiert von: 10 — Biyun Wang · Wen Zhang · Xiaonan Hong ·. Ye Guo · Jin Li. Received: 24 December Accepted: 2 March Published online: 15 March
Phase I dose-escalating study of 24-h continuous infusion ...Springer
link.springer.com
von B Wang · · Zitiert von: 10 — Biyun Wang, Wen Zhang, Xiaonan Hong, Ye Guo & Jin Li. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai...
Phase I dose-escalating study of 24-h continuous infusion of...
link.springer.com
Biyun Wang (1) (2); Wen Zhang (1) (2); Xiaonan Hong (1) (2); Ye Guo (1) (2); Jin Li · (1) (2). Author Affiliations. 1. Department of Medical ...
Alle Infos zum Namen "Xiaonan Hong"
A Chinese subgroup analysis of the phase III PHOENIX trialNational Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von J Zhu · — Jun Zhu , Xiaonan Hong , Yu Qin Song , Brendan Hodkinson , Sriram Balasubramanian , Songbai Wang , Qingyuan Zhang , Yuankai Shi , Huiqiang ... von GS Nowakowski · · Zitiert von: 116 — ... Annalisa Chiappella , Randy D Gascoyne , David W Scott , Qingyuan Zhang , Wojciech Jurczak , Muhit Özcan , Xiaonan Hong , Jun Zhu ...
A Phase III study of lenalidomide plus rituximab versus ...elsevierpure.com
mayoclinic.elsevierpure.com
von JP Leonard · · Zitiert von: 292 — John P. Leonard, Marek Trneny, Koji Izutsu, Nathan H. Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S. Nowakowski, ...
Chinese Women's Struggle for Human Rights under the ...Atlantis Press
www.atlantis-press.com
von L Zhang · — Chinese Women's Struggle for Human Rights under the Influence of Marxist Ideology in the Early 20th Century. Authors. Lulu Zhang, Xiaonan Hong.
Efficacy and safety of obinutuzumab for the first-line ...MedNexus
mednexus.org
von X Hong · · Zitiert von: 1 — Xiaonan Hong, Yuqin Song, Yuankai Shi, Qingyuan Zhang, Wei Guo, Gang Wu, Junmin Li, Jifeng Feng, Anastasiia Kinkolykh, Andrea Knapp, ...
Interim PET/CT result is the sole prognostic factor of surviv..|INISInternational Atomic Energy Agency
inis.iaea.org
von J Jia · — Jia Jin; Yizhen Liu; Qunling Zhang; Kai Xue; Zuguang Xia; Junning Cao; Xiaonan Hong (Fudan University Shanghai Cancer Center, Shanghai (China).
Prognostic significance of clinical characteristics and ...Sage Publications
journals.sagepub.com
Lianfang Liu, Zezhou Wang, Baohua Yu, Zuguang Xia, Qunling Zhang, Dongmei Ji, Xiaojian Liu, Fangfang Lv, Xiaonan Hong, Shaoli Song, and Junning Cao ...
TurabianMediterranean Journal of Hematology and Infectious Diseases
www.mjhid.org
... Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, ...
CrossRef Text and Data MiningCancer Research and Treatment
www.e-crt.org
— Biyun Wang, Wen Zhang, Xiaonan Hong, Ye Guo, Jin Li. Cancer Chemotherapy and Pharmacology ;63(2): Crossref logo.
Randomized Phase III Trial of Ibrutinib and ASCO JournalsASCO Journals
ascopubs.org
by A Younes · · Cited by 346 — Anas Younes, MD ; Laurie H. Sehn, MD ; Peter Johnson, MD ; Pier Luigi Zinzani, MD, PhD ; Xiaonan Hong, MD ... by GS Nowakowski · · Cited by 99 — ... Annalisa Chiappella, Randy D. Gascoyne, David W. Scott, Qingyuan Zhang, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, ... › doi › abs › jco › doi › abs › jco
Faculty Publications | Department of Biology - UNA Scholarly ...ir.una.edu › bio_facpub
ir.una.edu
... diffuse large B-cell lymphoma, Yizhen Liu, Yumei Liu, Ping Zhao, Qunling Zhang, Xiaojian Liu, Fangfang Lv, Xiaonan Hong, Junning Cao, and Kai Xue.
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo...
www.physiciansweekly.com
· ... Zhang,Wojciech Jurczak,Muhit Özcan,Xiaonan Hong,Jun Zhu,Jie Jin,David Belada,Juan Miguel Bergua,Francesco Piazza,Heidi Mócikova,Anna Lia ...
Phase I dose-escalating study of 24-h continuous infusion of...
pubmed.ncbi.nlm.nih.gov
Authors. Biyun Wang , Wen Zhang, Xiaonan Hong, Ye Guo, Jin Li. Affiliation. 1 Department of Medical Oncology, Cancer Hospital Fudan University, Shanghai ...
Switching Fractioned R-CHOP Cycles to Standard R X-molwww.x-mol.com › paper › adv
en.x-mol.com
Yizhen Liu,Yumei Liu,Ping Zhao,Qunling Zhang,Xiaojian Liu,Fangfang Lv,Xiaonan Hong,Junning Cao,Kai Xue. Background: Primary gastric ...
Switching fractioned R-CHOP cycles to standard R-CHOP ...www.researchsquare.com › article
www.researchsquare.com
Yi-Zhen Liu, Yu-Mei Liu, Ping Zhao, Qunling Zhang, Xiaojian Liu, Fangfang Lv, Xiaonan Hong, Junning Cao, Kai Xue ...
Verwandte Suchanfragen zu Xiaonan Hong
| Adriana Scheliga Dong Wang |
Person "Hong" (2) Vorname "Xiaonan" (18) Name "Hong" (3443) |
sortiert nach Relevanz / Datum